To include your compound in the COVID-19 Resource Center, submit it here.

FDA grants breakthrough therapy designation to Zogenix's ZX008

Zogenix Inc. (NASDAQ:ZGNX) said FDA granted breakthrough therapy designation to ZX008 to treat seizures associated

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE